Vitamin D supplementation and improvement of pneumonic children at a tertiary pediatric hospital in Egypt: A randomized controlled trial
Medicine (Baltimore). 2021 Apr 2;100(13):e25011. doi: 10.1097/MD.0000000000025011.
John Rene Labib 1, Sally Kamal Ibrahem 1, Mohamed M Ismail 1, Shaimaa A M Abd El Fatah 2, Amal Samir Sedrak 2, Mona Adel Soliman Attia 2, Hadeel Mohammad El-Hanafi 3, Mai Hamed Kamel 3
Exactly how many fewer deaths is hidden in the PDF, which is hiding behind a paywall
- Pneumonia Risk, intensity, and mortality all associated with low vitamin D in VitaminDWiki
- Acute pneumonia in children 3X less likely if greater than 30 ng of vitamin D – Jan 2021
- Pneumonia in Egyptian Children 3.6 X more likely if poor Vitamin D Receptor – Aug 2018
- Recurrence of child pneumonia delayed by 100000 IU of vitamin D – RCT Oct 2010
Background: Despite the well-recognized effect of vitamin D in metabolism and homeostasis, there is now growing interest in its probable association with pneumonia. This study aims to supply vitamin D3 (Cholecalciferol) (100,000 IU) to pneumonic children to minimize the duration of illness and improve their outcome.
Methods: A double-blinded, randomized, placebo-controlled trial was conducted in a Pediatric Cairo University affiliated hospital. An intervention arm (93 children) and a control arm (98 children), who had pneumonia with an insufficient or deficient level of vitamin D and whose parental permission was obtained, were enrolled in the trial. All children were treated with antibiotics according to WHO guidelines. Children were given a single injection of 1 mL of 100,000 IU of vitamin D3 or placebo. Clinical data were recorded every eight hours for all children. Outcomes were assessed 7 days after vitamin D injection.The primary outcome variable was the change in serum level of 25(OH)D, while the secondary outcomes were the medical state of the assigned cases (improvement or death) and duration between enrollment and hospital discharge for improved cases.
Results: In the supplementation group, the percentage of patients who suffered either deficient (38.7%) or insufficient levels (61.3%) of 25 (OH)D at day one had significantly decreased in the seventh day to (11.8%) and (52.7%), respectively. Kaplan- Meier plots highlighted that the median time to recover of the placebo group was significantly longer than that of the supplementation group (Log Rank P value < .001).
Conclusion: VDD was detected in pediatric critical care children. In pneumonic children with high VDD, it is illustrated that Vitamin D supplementation is accompanied by lowered mortality risk and pSOFA scores, reduced time to recover, and improved PaO2/FiO2.
Trial registration: Trial Identifier number: NCT04244474. Registered on 27 January 2020- Retrospectively registered at ttps://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0009JXO&selectaction=Edit&uid=U0004UO8&ts=152&cx=9cceq6.| ClinicalTrials.gov]
- Elsevier, Kliegman RM, Geme JSt. Nelson Textbook of Pediatrics. 21th ed.2019;2088-94.
- Tiewsoh K, Lodha R, Pandey RM, et al. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatric 2009;9:15.
- UNICEF. Levels & Trends in Child Mortality. Estimates developed by the UN Inter-agency Group for Child Mortality Estimation. Report 2019. Available at: https://childmortality.org/wpcontent/uploads/2019/10/UN-IGME-Child-Morta.... Accessed March, 2019.
- Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008;88:491S–9S.
- Underwood MA, Bevins CL. Defensin-barbed innate immunity: clinical associations in the pediatric population. Pediatrics 2010;125:1237–47.
- Tavahen N, Pourmoghaddas Z, Esteki B, et al. Active form and reservoir form of Vitamin D in children with acute lower respiratory infections and its association with severity of the infection. Arch Pediatr Infect Dis 2019;7:e83431.
- Larkin A, Lassetter J. Vitamin D deficiency and acute lower respiratory infections in children younger than 5 years: identification and treatment. J Pediatr Health Care 2014;28:572–82. quiz 583-584.
- Bergman P, Lindh AU, Bjorkhem-Bergman L, et al. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2013;8:e65835.
- RamJat K. Vitamin D deficiency and lower respiratory tract infections in children: a systematic review and meta-analysis of observational studies. Trop Doct 2017;47:77–84.
- Banajeh SM. Nutritional rickets and vitamin D deficiency--association with the outcomes of childhood very severe pneumonia: a prospective cohort study. Pediatr Pulmonol 2009;44:1207–15.
- Albanna EAM, Ali YF, Elkashnia RAM. Vitamin D and LL-37 in children with pneumonia. Egypt J Pediatr Allergy Immunol 2010;8:81–6.
- Hashemian H, Heidarzadeh A. Role of Vitamin D 25(OH) D deficiency in development of pneumonia in children. Arch Pediatr Infect Dis 2017;5:e57276.
- MedCalc Statistical Software version 18.2.1. MedCalc Software bvba. Ostend, Belgium; 2018. Available at: http://www.medcalc.org.
- Basu S, Gupta R, Mitra M, et al. Prevalence of Vitamin D deficiency in a pediatric hospital of Eastern India. Indian J Clin Biochem 2015;30:167–73.
- World Health Organization. Technical Bases for the WHO Recommendations on the Management of Pneumonia in Children at First-Level Health Facilities.(1995) Report No. WHO/ARI /91.20. Geneva: WHO. Available at: https://www.who.int/maternal_child_adolescent/documents/ari_91_20/en/
- Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr 2012;142:498–507.
- World Health Organization. Revised WHO Classification and Treatment of Childhood Pneumonia at Health Facilities. Evidence summaries, 2014. Available at: https://apps.who.int/iris/bitstream/handle/10665/137332/WHO_FWC_MCA_14.9...
- Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Disease Society of America. Clin Infect Dis 2011;53:e25–76.
- Han JE, Jones JL, Tangpricha V, et al. High dose Vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized control trial. J Clin Transl Endocrinol 2016;4:59–65.
- Badawia NES, Algebalyb HF, ElSayed R, et al. Vitamin D deficiency in critically ill children. Kasr Al Ainy Med J 2017;23:6–11.
- Aşilioğlu N, Çiğdem H, Paksu MS. Serum Vitamin D status and outcome in critically ill children. Indian J Crit Care Med 2017;21:660–4.
- Sankar J, Lotha W, Ismail J, et al. Vitamin D deficiency and length of pediatric intensive care unit stay: a prospective observational study. Ann Intensive Care 2016;6:3.
- McNally JD, Menon K, Chakraborty P, et al. The association of vitamin D status with pediatric critical illness. Pediatrics 2012;130:429–36.
- McNally JD, Nama N, O’Hearn K, et al. Vitamin D deficiency in critically ill children: a systematic review and meta-analysis. Crit Care 2017;21:287.
- Cariolou M, Cupp MA, Evangelou E, et al. Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis. BMJ Open 2019;9:e027666doi: 10.1136/bmjopen-2018-027666. - DOI
- Quraishi SA, De Pascale G, Needleman JS, et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial. Crit Care Med 2015;43:1928–37.
- Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012;95:1357–64.
- Gottschlich MM, Mayes T, Khoury J, et al. Clinical trial of Vitamin D2vs D3 supplementation in critically ill pediatric burn patients. J Parent Enteral Nutr 2017;41:412–21.
- McNally JD, Amrein K, O’Hearn K, et al. Study protocol for a phase II dose evaluation randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study). Pilot Feasibility Stud 2017;3:70.
- Ebenezer K, Job V, Antonisamy B, et al. Serum Vitamin D status and outcome among critically ill children admitted to the pediatric intensive care unit in South India. Indian J Pediatr 2016;83:120–5.
- Khorasani NR, Moazzami B, Tajrishi FZ, et al. The association between low levels of Vitamin D and clinical outcomes in critically-ill children: a systematic review and meta-analysis. Fetal Pediatr Pathol 2019;11:1–5.
- McNally JD, Amrein K. Vitamin D deficiency in pediatric critical care. J Pediatr Intensive Care 2016;5:142–53.
- Shah SK, Lodha R. Implications of Vitamin D deficiency in critically ill children. Indian J Pediatr 2015;82:977–9.
- Han JE, Jones JL, Tangpricha V, et al. High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial. J Clin Transl Endocrinol 2016;4:59–65.
- Tiewsoh K, Lodha R, Pandey RM, et al. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatrics 2009;9:15.
- Grossmann RE, Zughaier SM, Kumari M, et al. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: a randomized, controlled trial. Dermatoendocrinol 2012;4:191–7.
- Braun AB, Gibbons FK, Litonjua AA, et al. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med 2012;40:63–72.
- Manaseki-Holland S, Qader G, Masher MI, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health 2010;15:1148–55.
- Cariolou M, Cupp MA, Evangelou E, et al. Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis. BMJ Open 2019;9:e027666.
- Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 2014;312:1520–30.